{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:15:30Z","timestamp":1766870130501,"version":"3.41.2"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Several factors are associated with the progression of chronic hepatitis C: comorbidities, lifestyle, and pathogenic factors, including immune response, apoptosis and heredity. Single nucleotide polymorphisms (SNPs) in the PNPLA3 and TM6SF2 genes are more widely studied genetic risk factors, while CXCL9\u201311 chemokines produced by hepatocytes in the process of infection are less well studied. Our aim was to evaluate the influence of CXCL9 rs10336, CXCL10 rs3921 and CXCL11 rs4619915 in liver fibrosis when analysed together with PNPLA3 rs738409 and TM6SF2 rs58542926. The study included 219 patients with chronic hepatitis C. SNP genotyping was performed by real-time PCR. Univariate and multivariate analyses were used to detect the association between SNPs and advanced fibrosis in a recessive genetic model. All SNPs had a minimum allele frequency &amp;gt;5%, and CXCL9 rs10336, CXCL10 rs3921 and CXCL11 rs4619915 were in high linkage disequilibrium (D\u2032 \u2265 0.84). In the multivariate analysis, we observed that male gender (P\u00a0=\u00a00.000), older age (P\u00a0=\u00a00.025), moderate to intense inflammatory activity (P\u00a0=\u00a00.002), moderate to accentuated hepatic steatosis (P\u00a0=\u00a00.026) and the CT genotype of the TM6SF2 rs58542926 SNP (P\u00a0=\u00a00.014) presented significant associations with advanced fibrosis. Overall, the CXCL9 rs10336, CXCL10 rs3921, CXCL11 rs4619915 and PNPLA3 rs738409 SNPs did not influence liver fibrosis among patients with chronic hepatitis C.<\/jats:p>","DOI":"10.1093\/femspd\/ftab007","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T20:13:27Z","timestamp":1611087207000},"source":"Crossref","is-referenced-by-count":2,"title":["Study of<i>CXCL9-11<\/i>gene polymorphisms in liver fibrosis among patients with chronic hepatitis C"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-6623","authenticated-orcid":false,"given":"Mariana Cavalheiro","family":"Magri","sequence":"first","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Stella Montanha","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anny Ayumi","family":"Iogi","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grayce Mendes","family":"Alves","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Manchiero","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca Peixoto","family":"Dantas","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamiris Vaz Gago","family":"Prata","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arielle Karen da Silva","family":"Nunes","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F\u00e1tima Mitiko","family":"Tengan","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigacao Medica em Hepatologia por Virus (LIM-47), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"},{"name":"Departamento de Molestias Infecciosas e Parasitarias, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Eneas de Carvalho Aguiar, 255. Bairro Cerqueira Cesar. Sao Paulo, SP, Brazil. CEP 05403-000"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"2021070821153618500_bib1","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/ijms20061277","article-title":"TM6SF2 and MBOAT7 Gene variants in liver fibrosis and cirrhosis","volume":"20","author":"Basyte-Bacevice","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2021070821153618500_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1590\/0037-8682-0402-2015","article-title":"Natural history of liver fibrosis progression in patients confected with hepatitis c virus and human immunodefi ciency virus type","volume":"49","author":"Bhattacharya","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"2021070821153618500_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.04.042","article-title":"Polymorphisms of chemokine receptor genes and clearance of hepatitis C virus infection in Chinese population","volume":"624","author":"Chen","year":"2017","journal-title":"Gene"},{"key":"2021070821153618500_bib4","doi-asserted-by":"crossref","first-page":"e824","DOI":"10.1002\/mgg3.824","article-title":"The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects","volume":"7","author":"Chen","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2021070821153618500_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/j.gastro.2007.12.044","article-title":"Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers","volume":"134","author":"Deng","year":"2008","journal-title":"Gastroenterology"},{"key":"2021070821153618500_bib6","doi-asserted-by":"crossref","first-page":"e027491","DOI":"10.1136\/bmjopen-2018-027491","article-title":"Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update","volume":"9","author":"Erman","year":"2019","journal-title":"BMJ Open"},{"key":"2021070821153618500_bib7","doi-asserted-by":"crossref","first-page":"468107","DOI":"10.1155\/2012\/468107","article-title":"Cytokines and HCV-Related Disorders","volume":"2012","author":"Fallahi","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"2021070821153618500_bib8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5009\/gnl15261","article-title":"PNPLA3 rs738409 polymorphism associated with hepatic steatosis and advanced fibrosis in patients with chronic hepatitis C Virus: A meta-analysis","volume":"10","author":"Fan","year":"2016","journal-title":"Gut Liver"},{"key":"2021070821153618500_bib9","doi-asserted-by":"crossref","first-page":"5878960","DOI":"10.1155\/2019\/5878960","article-title":"Immunomodulation of CXCL10 secretion by hepatitis C Virus: Could CXCL10 be a prognostic marker of chronic hepatitis C?","volume":"2019","author":"Ferrari","year":"2019","journal-title":"J Immunol Res"},{"key":"2021070821153618500_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1053\/gast.2003.50018","article-title":"Progression of fibrosis in chronic hepatitis C","volume":"124","author":"Ghany","year":"2003","journal-title":"Gastroenterology"},{"key":"2021070821153618500_bib11","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510290401","article-title":"Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis","volume":"29","author":"Hourigan","year":"1999","journal-title":"Hepatology"},{"key":"2021070821153618500_bib12","doi-asserted-by":"crossref","first-page":"e0182204","DOI":"10.1371\/journal.pone.0182204","article-title":"Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"2021070821153618500_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40169-017-0156-3","article-title":"CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study","volume":"6","author":"Jim\u00e9nez-Sousa","year":"2017","journal-title":"Clin Transl Med"},{"key":"2021070821153618500_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2018.04.008","article-title":"PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study","volume":"103","author":"Jim\u00e9nez-Sousa","year":"2018","journal-title":"J Clin Virol"},{"key":"2021070821153618500_bib15","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"2021070821153618500_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.15403\/jgld.2014.1121.261.pnp","article-title":"PNPLA3 and RNF7 Gene variants are associated with the risk of developing liver fibrosis and cirrhosis in an eastern European population","volume":"26","author":"Kupcinskas","year":"2017","journal-title":"J Gastrointestin Liver Dis"},{"key":"2021070821153618500_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.gtc.2015.07.003","article-title":"Natural history of hepatitis C","volume":"44","author":"Lingala","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"2021070821153618500_bib18","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1038\/s41598-017-09548-9","article-title":"The effect of the TM6SF2 E167K variant on liver steatosis and fibrosis in patients with chronic hepatitis C: a meta-analysis","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"2021070821153618500_bib19","doi-asserted-by":"crossref","first-page":"115025","DOI":"10.1016\/j.diagmicrobio.2020.115025","article-title":"The influence of gene-chronic hepatitis C virus infection on hepatic fibrosis and steatosis","volume":"97","author":"Magri","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021070821153618500_bib20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1186\/s12879-017-2887-6","article-title":"The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C","volume":"17","author":"Manchiero","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2021070821153618500_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27811","article-title":"Transmembrane 6 Superfamily Member 2 Gene E167K. Variant impacts on steatosis and liver damage in chronic hepatitis C patients","volume":"62","author":"Milano","year":"2015","journal-title":"Hepatology"},{"key":"2021070821153618500_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1365-2893.2011.01580.x","article-title":"Genetic polymorphism in cyclooxygenase-2 promoter affects hepatic inflammation and fibrosis in patients with chronic hepatitis C","volume":"19","author":"Miyashita","year":"2012","journal-title":"J Viral Hepat"},{"key":"2021070821153618500_bib23","doi-asserted-by":"crossref","first-page":"e81312","DOI":"10.1371\/journal.pone.0081312","article-title":"No correlation between PNPLA3 rs738409 genotype and fatty liver and hepatic cirrhosis in Japanese patients with HCV","volume":"8","author":"Nakamura","year":"2013","journal-title":"PLoS One"},{"key":"2021070821153618500_bib24","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1371\/journal.pntd.0001867","article-title":"Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10","volume":"6","author":"Nogueira","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"2021070821153618500_bib25","doi-asserted-by":"crossref","first-page":"e14612","DOI":"10.1097\/MD.0000000000014612","article-title":"Association between CXCL9\/10 polymorphisms and acute rejection of liver allograft","volume":"98","author":"Ostojic","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2021070821153618500_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/QAI.0000000000000491","article-title":"Single Nucleotide Polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV\/HCV-coinfected patients","volume":"68","author":"Pineda-Tenor","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2021070821153618500_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jcv.2014.08.020","article-title":"CXCL9, CXCL10 and CXCL11 polymorphisms are associated with sustained virologic response in HIV\/HCV-coinfected patients","volume":"61","author":"Pineda-Tenor","year":"2014","journal-title":"J Clin Virol"},{"key":"2021070821153618500_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"2021070821153618500_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"2021070821153618500_bib30","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.3748\/wjg.v22.i38.8509","article-title":"TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency\/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype","volume":"22","author":"Sagnelli","year":"2016","journal-title":"World J Gastroenterol"},{"key":"2021070821153618500_bib31","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1111\/j.1478-3231.2008.01927.x","article-title":"The history of the \u201cnatural history\u201d of hepatites","volume":"29","author":"Seeff","year":"2009","journal-title":"Liver Int"},{"key":"2021070821153618500_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2009.06.006","article-title":"Genetic association between a chemokine gene CXCL-10 (IP-10, interferon gamma inducible protein 10) and susceptibility to tuberculosis","volume":"406","author":"Tang","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2021070821153618500_bib33","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1186\/s12885-019-6173-4","article-title":"Association of TM6SF2 rs58542926 T\/C gene polymorphism with hepatocellular carcinoma: a meta-analysis","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Cancer"},{"key":"2021070821153618500_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C","volume":"20","author":"The French METAVIR Cooperative Study Group","year":"1994","journal-title":"Hepatology"},{"key":"2021070821153618500_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrgastro.2016.176","article-title":"Global epidemiology and burden of HCV infection and HCV-related disease","volume":"14","author":"Thrift","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2021070821153618500_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"},{"key":"2021070821153618500_bib37","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"2021070821153618500_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.24618","article-title":"Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males","volume":"55","author":"White","year":"2012","journal-title":"Hepatology"},{"key":"2021070821153618500_bib39","doi-asserted-by":"crossref","first-page":"e81329","DOI":"10.1371\/journal.pone.0081329","article-title":"CXCL10 gene promoter polymorphism -1447A.G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria","volume":"8","author":"Wilson","year":"2013","journal-title":"PLoS One"},{"key":"2021070821153618500_bib40","doi-asserted-by":"crossref","first-page":"e72799","DOI":"10.1371\/journal.pone.0072799","article-title":"Association of interferon-gamma induced protein 10 promoter polymorphisms with the disease progression of hepatitis B virus infection in Chinese han population","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"key":"2021070821153618500_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/jvh.12053","article-title":"Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C","volume":"20","author":"Zampino","year":"2013","journal-title":"J Viral Hepat"},{"key":"2021070821153618500_bib42","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1007\/s00705-018-3872-0","article-title":"Association of CXCR2 genotype variations with HCV clearance in a Chinese population","volume":"163","author":"Zang","year":"2018","journal-title":"Arch Virol"},{"key":"2021070821153618500_bib43","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/infdis\/jiw332","article-title":"Fibrosis progression in patients with chronic hepatitis C virus infection","volume":"214","author":"Zeremski","year":"2016","journal-title":"J Infect Dis"},{"key":"2021070821153618500_bib44","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2893.2006.00838.x","article-title":"The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection","volume":"14","author":"Zeremski","year":"2007","journal-title":"J Viral Hepat"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/advance-article-pdf\/79\/3\/ftab007\/36649312\/ftab007.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/79\/3\/ftab007\/36650079\/ftab007.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/79\/3\/ftab007\/36650079\/ftab007.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T03:15:23Z","timestamp":1697598923000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftab007\/6105222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,20]]}},"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftab007","relation":{},"ISSN":["2049-632X"],"issn-type":[{"type":"electronic","value":"2049-632X"}],"subject":[],"published-other":{"date-parts":[[2021,4]]},"published":{"date-parts":[[2021,1,21]]},"article-number":"ftab007"}}